Stockscreener 앱 받기
31.83
1.82%
0.57
시장 영업 전:
31.98
0.15
+0.47%
Harmony Biosciences Holdings Inc 주식(HRMY)의 최신 뉴스
CX Institutional Increases Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Capital Management Corp VA Sells 41,191 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
HRMY stock on track for best intraday gains in 18 months — what did Mizuho analysts say? - MSN
Price-Driven Insight from (HRMY) for Rule-Based Strategy - Stock Traders Daily
Earnings Preview: HRMY to Report Financial Results Pre-market on May 07 - Moomoo
M3Sixty Small Cap Growth Fund's Harmony Biosciences Holdings Inc(HRMY) Holding History - GuruFocus
Harmony Bio spikes after new Wakix patent litigation - MSN
Harmony Biosciences (HRMY) Projected to Post Quarterly Earnings on Thursday - MarketBeat
A Look At Harmony Biosciences (HRMY) Valuation After CFO Appointment And Reaffirmed 2026 Revenue Outlook - Sahm
Top 5 US Stocks To Buy In May 2026 - Investing.com
Q3 Earnings Estimate for HRMY Issued By HC Wainwright - MarketBeat
Harmony Biosciences Appoints Glenn Reicin as CFO, Reaffirms Outlook - MyChesCo
Assessing Harmony Biosciences (HRMY) Valuation After Recent Share Price Momentum And Pipeline Expectations - Yahoo Finance
H.C. Wainwright reiterates Harmony Biosciences stock rating on IP litigation outlook By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Harmony Biosciences stock rating on IP litigation outlook - Investing.com Australia
Research Analysts Issue Forecasts for HRMY Q1 Earnings - MarketBeat
Why Harmony Biosciences (HRMY) Reaffirmed 2026 Revenue Guidance and Hired a Markets-Focused CFO - Yahoo Finance
Harmony Biosciences (HRMY) Attracts Buy Rating Amid IP Litigatio - GuruFocus
Harmony Bio granted FDA label expansion for Wakix in children with narcolepsy - MSN
Harmony Biosciences Holdings, Inc. (HRMY) Latest Stock News & Headlines - Yahoo Finance
Press Release: Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 - 富途牛牛
Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 - Business Wire
Analysts Are Bullish on These Healthcare Stocks: Guardant Health (GH), Crescent Biopharma (CBIO) - The Globe and Mail
Ruffer LLP Purchases Shares of 40,993 Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Legend Biotech (LEGN) moves 18.4% higher: Will this strength last? - MSN
Oppenheimer raises Harmony Biosciences stock price target on patent strength - Investing.com
Harmony Biosciences (HRMY) Is Up 9.7% After New CFO Hire And Reiterated 2026 Guidance – Has The Bull Case Changed? - simplywall.st
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $72 at Oppenheimer - StreetInsider
HRMY.O - Reuters
HRMY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Harmony Biosciences (HRMY) Shares Rise on Positive Patent Litiga - GuruFocus
HRMY Stock On Track For Best Intraday Gains In 18 Months — What Did Mizuho Analysts Say? - Stocktwits
Harmony Biosciences (HRMY) Secures Patent Lawsuit Against Generi - GuruFocus
Harmony (HRMY) Sees 14% Surge Following Patent Lawsuit Discovery - GuruFocus
2.45%
자본화:
|
볼륨(24시간):